|
The University of Texas
M. D.
Anderson Cancer
Center
G3 Non-OR Procedure
Suite and Cath Lab - Request for Proposals
Overview
M. D. Anderson is known throughout the world for
high-quality cancer care, research, academic programs and prevention
services. Since its establishment in 1941, M. D. Anderson has made major
contributions to improve the outlook for cancer patients everywhere.
M. D. Anderson was one of the first three federally
designated comprehensive cancer centers by the National Cancer Act of 1971. A
survey of health professionals has routinely ranked M. D. Anderson as one of
the two premier cancer centers in the nation for the past eight years. Over
55,000 persons annually seek care at M. D. Anderson. The team approach to
cancer care, pioneered at M. D. Anderson, has been strengthened by consolidating
specialty clinics into multi-disciplinary care centers that allow patients to
receive more ambulatory care and treatment in a single location.
M. D. Anderson offers one of the largest bone marrow
and stem cell transplantation programs, as well as clinical trials to improve
existing therapies. Teams of clinical specialists collaborate with scientists
on problems of common interest and test theories that shorten the application
of better treatment methods. Translational
research studies are responsible for the promising field of chemoprevention,
which uses synthetic vitamins to reverse pre-malignant lesions and halt the
recurrence of some cancers, and for innovative gene therapy strategies being
evaluated for several forms of cancer.
Existing Houston facilities
include the latest M. D. Anderson Main Complex facility completed in 1998 and
designated as the Alkek Building. This facility consists of more than 1.2
million square feet of new space and is dedicated to clinic, research, and
patient care in the Texas Medical Center. During 2005, Owner completed
construction of the George and Cynthia Mitchell Basic Sciences Research
Building, Ambulatory Clinical Building, the Cancer Prevention Building, and
the South Campus Research Building Two. Owner is currently constructing the
T. Boone Pickens Academic Tower, which is scheduled to be occupied during
2008. Educational programs train about 2,000 scientists, physicians, and
allied health professionals annually. A new Cancer Prevention Center provides
sophisticated cancer risk assessment and early detection, genetic testing,
counseling, classes to address harmful lifestyle habits, and long-term
follow-up for recovering cancer patients. Studies of the environmental causes
of cancer are conducted at M. D.
Anderson Science Park in nearby Bastrop County. The Bastrop site also
includes a center to provide veterinary resources for research.
Mission. The
mission of M. D. Anderson is to eliminate cancer in Texas, the nation and the world through
outstanding integrated programs in patient care, research, education and
prevention.
Vision. We shall
be the premier cancer center in the world, based on the excellence of our
people, our research-driven patient care and our science. We are Making
Cancer History.
Core Values.
Caring. By our words and actions, we create a caring
environment for everyone.
Integrity. We work together to merit the trust of our colleagues and
those we serve.
Discovery. We embrace creativity and seek new knowledge.
PROJECT DESCRIPTION AND SCOPE:
The Project
is a collaborative effort for Anesthesiology assisted Non-OR Procedures,
Nursing (stage two recovery and Cardiology (Cath Lab)). The project includes
the renovation of clinical space on level 3 of the Alkek Patient Tower
totaling approximately 5,400 square feet. Proposed spaces include a new
Catheterization Lab with adjacent support spaces for Cardiology, 3 Non-OR
Procedure Rooms, Exam Room and support spaces for Anesthesiology, a new staff
lounge, change areas and the remodel of the main reception space and patient
waiting area. The stage two recovery area will remain in its existing
condition and will be operational during the construction phase
The following Sections identified below form a part of this
Request for Proposal (RFP).
ADDENDUM 3 RESPONDENTS
PRICING AND DELIVERY PROPOSAL ISSUED OCTOBER 13, 2008
ADDENDUM
2 ISSUED OCTOBER 9, 2008
SIGN IN SHEETS FROM PRE-PROPOSAL MEETING
ISSUED OCTOBER 9, 2008
GOSSEN LIVINGSTON DRAWING CLARIFICATION ADDENDUM ISSUED OCTOBER 9,
2008
ADDENDUM 1
ISSUED OCTOBER 8, 2008
ADDENDUM
1 REQUEST FOR PROPOSAL (RFP) ISSUED OCTOBER 8, 2008
ADDENDUM 1 REQUEST FOR INFORMATION (RFI) ISSUED OCTOBER 8, 2008
REQUEST FOR PROPOSAL (RFP)
ATTACHMENT
A-DRAFT AGREEMENT
RIDER 1 TO THE DRAFT AGREEMENT, JOINT
COMMISSION
ATTACHMENT B-EXHIBIT H, POLICY ON UTILIZATION OF HISTORICALLY UNDERUTILIZED
BUSINESSES
ATTACHMENT C- RIDER 105; VENDOR
AFFIRMATION
ATTACHMENT D-RIDER 106; PREMISES RULES
ATTACHMENT
E REQUEST FOR INFORMATION
|
